Minocycline inhibits the enhancement of antidromic primary afferent stimulation-evoked vasodilation following intradermal capsaicin injection.
Neurogenic inflammation is induced by inflammatory mediators released in peripheral tissue from primary afferent nociceptors. Our previous studies suggest that neurogenic inflammation induced by intradermal injection of capsaicin results from the enhancement of dorsal root reflexes (DRRs), which involve antidromic activation of dorsal root ganglion (DRG) neurons. Numerous studies have reported the important role of glial modulation in pain. However, it remains unclear whether glial cells participate in the process of neurogenic inflammation-induced pain. Here we tested the role of DRG satellite glial cells (SGCs) in this process in anesthetized rats by administration of a glial inhibitor, minocycline. Electrical stimuli (ES, frequency 10 Hz; duration 1 ms; strength 3 mA) were applied to the cut distal ends of the L4-5 dorsal roots. The stimuli evoked antidromic action potentials designed to mimic DRRs. Local cutaneous blood flow in the hindpaw was measured using a Doppler flow meter. Antidromic ES for 10 min evoked a significant vasodilation that could be inhibited dose-dependently by local administration of the calcitonin gene-related peptide receptor antagonist, CGRP8-37. Pretreatment with capsaicin intradermally injected into the hindpaw 2h before the ES enhanced greatly the vasodilation evoked by antidromic ES, and this enhancement could be reversed by minocycline pretreatment. Our findings support the view that neurogenic inflammation following capsaicin injection involves antidromic activation of DRG neurons via the generation of DRRs. Inhibition of neurogenic inflammation by minocycline is suggested to be associated with its inhibitory effect on SGCs that are possibly activated following capsaicin injection.
Gong
Kerui
K
Department of Psychology, University of Texas at Arlington, TX 76019, USA.
Yue
Yue
Y
Zou
Xiaoju
X
Li
Dingge
D
Lin
Qing
Q
D000200:Action Potentials; D000818:Animals; D002211:Capsaicin; D004558:Electric Stimulation; D005727:Ganglia, Spinal / Q000187:drug effects / Q000503:physiopathology; D006614:Hindlimb / Q000098:blood supply; D007271:Injections, Intradermal; D008297:Male; D008911:Minocycline / Q000494:pharmacology*; D020078:Neurogenic Inflammation / Q000139:chemically induced / Q000503:physiopathology*; D009457:Neuroglia / Q000187:drug effects / Q000502:physiology*; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow; D027161:Satellite Cells, Perineuronal / Q000187:drug effects / Q000502:physiology*; D014664:Vasodilation
D008911:Minocycline; D002211:Capsaicin